Streetbeat News

Products Services

PLTR

Palantir shares rise following an extended enterprise agreement with BP, introducing new AI capabilities using Palantir's AIP software.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:12 pm

LOT

Lotus Technology Inc. (NASDAQ:LOT) has started delivering its Eletre model, an intelligent hyper SUV, in Korea and Japan. This move is part of Lotus's strategy to expand its presence in key luxury markets, leveraging its strong brand heritage and upgraded sales network.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:12 pm

INTC

NVDA

Peter Schiff warns investors about the risks of irrational exuberance in tech stocks and cryptocurrencies, using Intel's decline as a cautionary tale. Intel has struggled due to product missteps and lack of vision, contrasting with Nvidia's success in AI. Intel's stock has significantly underperformed, and the company is considering cost-cutting measures.

Portfolio Pulse from Shanthi Rexaline

September 09, 2024 | 12:11 pm

BTCUSD

ETHUSD

JPMorgan's report highlights the need for new catalysts in the cryptocurrency market to boost retail engagement and reverse the recent downtrend. Despite a decline in market value, trading volumes for Bitcoin and Ethereum increased. However, ETFs tied to these cryptocurrencies underperformed, with Bitcoin ETFs experiencing net outflows.

Portfolio Pulse from Murtuza Merchant

September 09, 2024 | 12:11 pm

MEOH

MRK

Several major stocks, including Methanex, Merck, and others, are experiencing declines in Monday's pre-market session. Methanex's shares fell 6.3% after announcing a $2.05 billion acquisition of OCI Global's methanol business. Merck's shares dropped 4.8% following clinical trial results.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 12:11 pm

HSAI

Hesai Technology has become the first company in the global lidar industry to receive the ISO 21448 Safety of the Intended Functionality certification. This achievement underscores Hesai's commitment to safety and innovation in lidar technology.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:10 pm

PLTR

SMMT

TERN

Palantir Technologies (PLTR) shares rose 8% due to its addition to the S&P 500 index. Terns Pharmaceuticals (TERN) saw a 42% increase after announcing positive Phase 1 trial results for TERN-601. Summit Therapeutics (SMMT) shares surged 62% following successful trial results for Ivonescimab in treating advanced NSCLC.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:09 pm

TARA

Protara Therapeutics announced results from the THRIVE-1 study, highlighting a high prevalence of choline deficiency and liver injury in patients dependent on parenteral support. The company plans to start a pivotal trial for IV Choline Chloride in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:09 pm

CVX

DRIP

FANG

GUSH

MTDR

XOM

Chevron and Exxon Mobil saw slight pre-market gains after last week's losses due to economic concerns. Direxion's leveraged oil ETFs, GUSH and DRIP, offer opportunities for bullish and bearish investors, respectively. GUSH is below key moving averages, while DRIP has gained due to falling oil prices.

Portfolio Pulse from Joshenomoto@benzinga.com

September 09, 2024 | 12:08 pm

TARA

Protara Therapeutics has completed the first cohort of its Phase 2 STARBORN-1 trial for TARA-002, targeting pediatric lymphatic malformations. Enrollment for additional cohorts is ongoing, with initial results anticipated in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:08 pm